Furthermore, a recent meta-analysis evaluating GP73 in 16 studies enrolling Chinese patients with HCV and HBC confirmed its accuracy as a marker for significant (AUC 0.818), advanced fibrosis (AUC 0.852), and cirrhosis (AUC 0.894) [51]. This evidence concerns the gene GOLM1 and Cirrhosis.